|
Unaudited Forward-Looking Statements Regarding Business Outlook | ||||||
|
(In millions, except per share data) | ||||||
|
| ||||||
|
Business Outlook |
|
Three Months Ending March 31, 2018 | ||||
|
|
|
GAAP Measure |
|
Non-GAAP Adjustments |
|
Non-GAAP Measure |
|
Gross margin |
|
59.0% |
|
0.25% |
|
59.25% |
|
|
|
|
|
|
|
|
|
Operating expenses |
|
$98 |
|
$18 |
|
$80 |
|
|
|
|
|
|
|
|
|
Effective tax rate |
|
(15.0)% |
|
27.5% |
|
12.5% |
|
|
|
|
|
|
|
|
|
Diluted earnings per share - low |
|
$0.42 |
|
$0.31 |
|
$0.73 |
|
|
|
|
|
|
|
|
|
Diluted earnings per share - high |
|
$0.48 |
|
$0.31 |
|
$0.79 |
|
Silicon Laboratories Inc. | |||
|
Condensed Consolidated Balance Sheets | |||
|
(In thousands, except per share data) | |||
|
(Unaudited) | |||
|
| |||
|
|
December 30, 2017 |
|
December 31,
|
|
Assets |
|
|
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents |
$ 269,366 |
|
$ 141,106 |
|
Short-term investments |
494,657 |
|
153,961 |
|
Accounts receivable, net |
71,367 |
|
74,401 |
|
Inventories |
73,132 |
|
59,578 |
|
Prepaid expenses and other current assets |
39,120 |
|
61,805 |
|
Total current assets |
947,642 |
|
490,851 |
|
Property and equipment, net |
127,682 |
|
129,559 |
|
Goodwill |
288,227 |
|
276,130 |
|
Other intangible assets, net |
83,144 |
|
103,565 |
|
Other assets, net |
88,387 |
|
81,739 |
|
Total assets |
$1,535,082 |
|
$1,081,844 |
|
|
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable |
$ 38,851 |
|
$ 39,577 |
|
Deferred income on shipments to distributors |
50,115 |
|
45,568 |
|
Other current liabilities |
73,359 |
|
54,550 |
|
Total current liabilities |
162,325 |
|
139,695 |
|
Long-term debt |
-- |
|
72,500 |
|
Convertible debt |
341,879 |
|
-- |
|
Other non-current liabilities |
77,862 |
|
42,691 |
|
Total liabilities |
582,066 |
|
254,886 |
|
Commitments and contingencies |
|
|
|
|
Stockholders' equity: |
|
|
|
|
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued |
-- |
|
-- |
|
Common stock – $0.0001 par value; 250,000 shares authorized; 42,707 and 41,889 shares issued and outstanding at December 30, 2017 and December 31, 2016, respectively |
4 |
|
4 |
|
Additional paid-in capital |
102,862 |
|
24,463 |
|
Retained earnings |
851,307 |
|
801,999 |
|
Accumulated other comprehensive income (loss) |
(1,157) |
|
492 |
|
Total stockholders' equity |
953,016 |
|
826,958 |
|
Total liabilities and stockholders' equity |
$1,535,082 |
|
$1,081,844 |
